ArticleJournal for immunotherapy of cancer2023

INBRX-120, a CD8α-targeted detuned IL-2 that selectively expands and activates tumoricidal effector cells for safe and durable in vivo responses.

Florian J Sulzmaier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.